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Abstract
Background: Obesity remains a major public health problem, associated with a cluster of metabolic abnormalities.
However, individuals exist who are very obese but have normal metabolic parameters. The aim of this study was to
determine to what extent differences in metabolic health in very obese women are explained by differences in
body fat distribution, insulin resistance and level of physical activity.
Methods: This was a cross-sectional pilot study of 39 obese women (age: 28-64 yrs, BMI: 31-67 kg/m
2) recruited
from community settings. Women were defined as ‘metabolically normal’ on the basis of blood glucose, lipids and
blood pressure. Magnetic Resonance Imaging was used to determine body fat distribution. Detailed lifestyle and
metabolic profiles of participants were obtained.
Results: Women with a healthy metabolic profile had lower intra-abdominal fat volume (geometric mean 4.78 l
[95% CIs 3.99-5.73] vs 6.96 l [5.82-8.32]) and less insulin resistance (HOMA 3.41 [2.62-4.44] vs 6.67 [5.02-8.86]) than
those with an abnormality. The groups did not differ in abdominal subcutaneous fat volume (19.6 l [16.9-22.7] vs
20.6 [17.6-23.9]). A higher proportion of those with a healthy compared to a less healthy metabolic profile met
current physical activity guidelines (70% [95% CIs 55.8-84.2] vs 25% [11.6-38.4]). Intra-abdominal fat, insulin
resistance and physical activity make independent contributions to metabolic status in very obese women, but
explain only around a third of the variance.
Conclusion: A sub-group of women exists who are metabolically normal despite being very obese. Differences in
fat distribution, insulin resistance, and physical activity level are associated with metabolic differences in these
women, but account only partially for these differences. Future work should focus on strategies to identify those
obese individuals most at risk of the negative metabolic consequences of obesity and on identifying other factors
that contribute to metabolic status in obese individuals.
Background
The health consequences of obesity are well established.
Obese individuals are at greater risk of cardiovascular
disease [1,2], largely through the association of obesity
with dyslipidaemia, hypertension, glucose intolerance
and diabetes [3]. It is well known that individuals who
are not obese can develop these metabolic abnormalities
[4,5]. What has been less widely appreciated until
recently is that a subset of obese individuals remains
free of any of these metabolic abnormalities. Current
data suggest that 20-30% of obese individuals appear to
maintain a favourable metabolic profile, more usually
associated with lean individuals [6,7]. Such individuals
have been termed ‘metabolically normal obese’ [8],
‘metabolically healthy but obese’ [9], ‘obese metabolically
normal’ [10] or described as having metabolically benign
obesity [11] or uncomplicated obesity [12] * Correspondence: louise.hayes@ncl.ac.uk
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effect on metabolic disorders remain to be fully
explained, but considerable interest has focused on the
role of body fat distribution. Vague first identified
android (upper-body or abdominal) obesity as being
associated with diabetes and atherosclerosis over
50 years ago [13]. Individuals with higher levels of cen-
tral adiposity are at greater risk of developing lipid and
glucose abnormalities than those with fat distributed
more peripherally [14,15]. Compelling evidence now
exists to suggest that excess intra-abdominal (visceral)
fat in particular confers an increased risk of developing
a metabolic disorder [16,17].
An increasing body of work exists to suggest that poor
metabolic health associated with obesity is mediated by
physical activity. Several studies have demonstrated that
higher physical activity and/or cardiorespiratory fitness
is associated with more favourable metabolic health
even among obese individuals [7,18-22].
Several recent studies have identified factors that are
associated with high insulin sensitivity and a favourable
metabolic profile in obese individuals. Although stan-
dard criteria to define the metabolically healthy obese
(MHO) individual are lacking, studies have suggested
that both lower intra-abdominal fat (IAF) [8,23] and
higher physical activity level [24] are associated with a
more healthy metabolic profile in obese individuals.
However, data on the association of directly measured
IAF and other cardiovascular risk factors with metabolic
health in the very obese (BMI ≥ 35) are scarce. Most
work in this field has focused on the overweight and
modestly obese (BMI 25-34) [11,25].
This paper presents a pilot study that arose from the
clinical observation that a substantial minority of indivi-
duals referred to a metabolic clinic for the management
of severe obesity had a healthy metabolic profile. Our
a i mw a st od e t e r m i n et ow h a te x t e n td i f f e r e n c e si n
metabolic health in very obese (class II and class III obe-
sity) women are explained by differences in body fat dis-
tribution, insulin resistance and level of physical activity.
Methods
Participants
Participants in this study were 39 very obese women
(median BMI 39.6 kg/m
2), aged 28-64 years and of Cau-
casian origin. The women were recruited from a num-
ber of sources, including an obesity clinic, dieticians and
from responding to a press release. Participants were
defined as ‘metabolically healthy’ (MHO) if they had a
fasting plasma glucose less than 6.1 mmol/l
-1,a2 - h o u r
post 75 g glucose challenge plasma glucose less than 7.8
mmol/l
-1, fasting triglycerides less than 2.2 mmol/l
-1,
HDL cholesterol greater than 1.1 mmol/l
-1and blood
pressure < 160/95 mmHg (n = 20). Participants not
meeting these criteria were defined as ‘metabolically
abnormal’ (MetAb). At the time this study was planned
there was a lack of consensus on appropriate cut points
for metabolic abnormalities, and for example, no inter-
nationally agreed definition of the metabolic syndrome.
Our approach to defining MHO was therefore some-
what pragmatic, combining WHO cut points for glucose
with cut points recommended locally and used in care
for people with diabetes and treatment within the obe-
sity service for lipids and blood pressure. Nineteen
women (9 MHO and 10 MetAb) were postmenopausal;
four (1 MHO; 3 MetAb) were currently using HRT.
Ethical approval for the study was obtained from the
Joint Ethics Committee of Newcastle and North
Tyneside Health Authority and the Newcastle Universi-
ties. Participants provided written consent for their
participation.
Assessment of body fat distribution
Body fat was assessed using magnetic resonance imaging
(MRI). Images were acquired on a Philips Intera 1.5 T
MRI system and rapid T1-weighted spin-echo sequence
with repetition time = 36 ms, echo time = 14 ms, flip
angle 120°, field of view = 60 cm, 256 × 256 matrix and
phase-conjugate symmetry. Participants were scanned
from the lower sternum to the mid thigh, by acquiring
10 mm thick transverse images with 30 mm gaps
between slices, as they lay in a supine position.
T h ev o l u m eo fI A Fa n dS C Ff a tc o m p a r t m e n t sw e r e
determined based on the method of Thomas [26]. The
MR images were transferred from the scanner to a PC
for analysis with custom written software. Fat appears as
a bright, high-intensity signal against a lower signal
from other tissues. Total fat content was determined in
the following fashion for each slice in the image. To
a u t o m a t i c a l l yl o c a t et h eo u t s i d eo ft h et o r s o ,t h es o f t -
ware examines pixels starting at the posterior left of the
image, and moving diagonally inwards, until two adja-
cent pixels brighter than 1/3 of the maximum signal
intensity are found. A threshold value is determined
from the sharpest edge in a 5 × 5 pixel neighbourhood
of this point, and a contour around the torso automati-
cally generated using this threshold. The mean (Mc)
and standard deviation (SDc) of the pixels along this
contour are determined and a final threshold Tf is set as
Tf =M c -S D c.
A new contour around the outside of the torso is
automatically generated using this threshold, and those
pixels with an intensity brighter than Tf are designated
as fat. The images were manually checked, and the con-
tour, and/or threshold level could be adjusted as neces-
sary. Each slice was reviewed manually to delete
unwanted voxels associated with, for example, bone
marrow and some stomach contents which give high
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Page 2 of 9intensity signals in the images. The total fat volume was
then determined by multiplying the number of pixels
brighter than the threshold Tf by the pixel size and sum
of slice thickness and slice gap.
Abdominal adipose tissue was defined as fat found in
the slices from the femoral heads to the top of the liver
or base of the lungs. Subcutaneous fat in this region was
identified as SCF. Fat that was within the peritoneum
was identified as IAF. To determine the IAF content, a
region encompassing the viscera was drawn manually by
an operator using a computer mouse. The IAF volume
was determined by multiplying the number of pixels
brighter than the threshold Tf in this region by the pixel
size and sum of slice thickness and slice gap. The sub-
cutaneous fat volume was determined by subtracting the
intra-abdominal fat volume from the total fat volume. A
measure of thigh fat was made by calculating the fat
area in one slice of one leg taken 80 mm (2 slices)
below the femoral heads slice.
Anthropometric measurements
Height was measured without shoes to the nearest
5 mm, with the head positioned so that the eye and the
external auditory meatus were level. Weight was mea-
sured to the nearest 100 g with the subject lightly
clothed. Waist circumference was measured, with the
waist unclothed and hip circumference over the subject’s
underwear, to the nearest centimetre at the midpoint
between the lower costal margin and the superior iliac
crest, and the hips over the greater trochanters. Sagittal
diameter was measured using an abdominal caliper as
the distance between the highest point of the abdomen
and the examination table with the participant lying
supine. Body Mass Index (BMI) was calculated as weight
(kg)/[height(m)
2].
Biochemical measurements
Participants attended for screening after an overnight
fast. Participants followed their usual diet and physical
activity pattern prior to screening. Fasting blood samples
w e r et a k e no na r r i v a la tt h ec l i n i c .P a r t i c i p a n t st h e n
took a standard oral glucose tolerance test. A venous
blood was taken after 30 minutes and 2 hours. Plasma
was separated by centrifugation within an hour (after
refrigeration of the sample). Serum insulin levels were
measured by an enzyme linked immunosorbent assay
(ELISA; Dako Ltd, Ely, UK). Plasma glucose concentra-
tions were measured on a Yellow Springs Analyser (YSI
Stat Plus 2300; Yellow Springs Instruments, Farnbor-
ough, UK). Insulin resistance (HOMA-IR) was estimated
using the Homeostasis Model Assessment, based on
fasting insulin and glucose [27].
Serum triglycerides were measured by a lipase/glycerol
kinase method on a Cobas Bio centrifugal analyser
(Roche Products Ltd, Welwyn, UK) using a commercial
kit (Sigma Diagnostics, Poole, UK). Serum HDL
cholesterol was estimated by measuring the supernatant
cholesterol concentration after precipitation of apolipo-
protein B containing lipoproteins with heparin and
manganese. LDL cholesterol was estimated using the
Friedwald formula. Non-esterfied fatty acid (NEFA) was
measured by a WAKO cabas analyser.
Blood pressure
Blood pressure was measured twice in the right arm
using an automated blood pressure monitor (Omron
M5-I) and a large cuff (for arm circumference 32-42
cm). The mean measurement was used in analysis.
Physical activity
Current level of physical activity was assessed by an
interviewer-administered questionnaire, based on the
Modifiable Activity Questionnaire [28], and by the use
of a pedometer (Yamax Digiwalker SW-200). The Modi-
fiable Activity Questionnaire collects information on lei-
sure time, occupational and transportation (walking or
cycling) physical activity. The amount of leisure time,
occupational and transportation physical activity under-
taken was recorded and assigned a metabolic equivalent
score (MET; 1 MET = 3.5 ml O2 uptake per kg/min)
according to the Compendium of Physical Activities
[29]. The reported daily average time spent in leisure
time activities, occupational activities (including sitting)
and walking or cycling for transport was summed and
total energy expenditure was computed assuming that
time not reported (i.e. 24 hours minus the sum of the
hours reported) was spent at rest and assigned a MET
score of 1. In addition participants were categorised
according to whether or not they met the current UK
recommendation for the level of physical activity
required to provide health benefits (at least 30 minutes
of moderate activity on at least 5 occasions per week
[30]).
Participants wore the pedometer for four days
(1 weekend day and 3 weekdays). A daily mean number
of steps walked was calculated.
Statistical analyses
All data analyses were performed using SPSS version
11.0. Measures of central tendency and variability are
presented for anthropometric and biochemical data.
Variables were log transformed where appropriate and
geometric means with 95% confidence intervals are pre-
sented. Where variable distributions were not normal-
ised by log transformation medians and inter-quartile
ranges are presented. Independent samples t-tests or
Mann-Whitney tests were used to compare means or
medians between cases and controls as appropriate.
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relationship between IAF and SCF and glucose, lipids
and blood pressure. Multivariable logistic regression was
used to identify determinants of MHO status. Odds
ratios (OR) and corresponding 95% confidence intervals
(CIs) are reported. The amount of variance explained by
independent variables in logistic regression analysis was
calculated as the difference in deviance between the null
model and the model with the independent variable
divided by the deviance in the null model [31]. A p
value < 0.05 was considered statistically significant.
Results
Body fat distribution and metabolic status
Twenty participants were classified as MHO, the
remaining 19 as MetAb. Participant characteristics are
shown in table 1. The MHO group differed significantly
from the MetAb group on each of the criteria upon
which participants were defined as MHO or MetAb
except systolic blood pressure (p = 0.193). A fairly large
(2.4 kg/m
2) non-significant difference in BMI between
the MHO and MetAb groups was found (Figure 1).
Analyses were repeated with adjustment for BMI. This
did not affect the results of the analyses and the unad-
justed results are presented here. The MHO group had
significantly less IAF than the MetAb (4.8 l vs 6.9 l; p =
0.006). The groups did not differ significantly in age.
The MHO group had significantly lower insulin resis-
tance, as estimated by HOMA (3.41 vs 6.67; p = 0.002)
(Figure 2). The 2 groups did not differ significantly in
abdominal SCF, thigh fat:IAF or waist:hip ratio (WHR).
Correlations between IAF and SCF and glucose, lipids,
blood pressure and HOMA-IR are shown in table 2. IAF
and SCF were significantly correlated with each other (r =
0.57, p < 0.001). IAF, but not SCF was significantly and
positively correlated with postload glucose (r = 0.31) and
systolic blood pressure (r = 0.35) and negatively with HDL
(r = -0.34). The correlation between IAF and triglycerides
approached statistical significance (r = 0.31, p = 0.054),
but there was no evidence of a correlation between SCF
and triglycerides. Both IAF and SCF were significantly cor-
related with diastolic blood pressure (r = 0.31 and r = 0.41
for IAF and SCF respectively). HOMA estimated insulin
resistance was not significantly correlated with either IAF
or SCF.
Physical activity
Physical activity questionnaire data and pedometer data
are summarised in table 3. The MHO group recorded a
higher mean number of steps walked per day (6548 vs
5427 in the MetAbs) but this difference was not statisti-
cally significant (p = 0.252) and the inclusion of ped-
ometer recorded steps per day in the logistic regression
model did not contribute to the explanatory power of
the model. MHOs reported greater daily energy expen-
diture in leisure time activities than the MetAbs, both
Table 1 Participant characteristics
MHO MetAb
n2 0 1 9 p
Central tendency Variability Central tendency Variability
Fasting glucose (mmol/l
-1)
a 5.37 (5.19-5.69) 6.17 (5.75-7.6) <0.001
2-hour glucose (mmol/l
-1)
b 5.63 (5.13-6.18) 7.72 (6.71-8.89) 0.001
Triglycerides (mmol/l
-1)
c 1.40 (0.43) 2.34 (0.72) <0.001
HDL cholesterol (mmol/l
-1) 1.48 (0.24) 1.32 (0.24) 0.036
Systolic BP (mmHg)
b 119.5 (113.3-126.0) 125.6 (118.4-135.4) 0.193
DiastolicBP (mmHg)
b 85.1 (82.5-87.8) 91.7 (86.4-97.4) 0.037
Weight (kg)
a 99.5 (88.2-112.3) 108.9 (93.7-119.5) 0.213
Body Mass Index (kg/m
2)
a 38.9 (35.1-43.7) 41.3 (38.1-47.9) 0.137
Age (yrs)
c 46.1 (9.8) 47.5 (9.6) 0.651
a Median (interquartile range), Mann-Whitney test for difference;
b Geometric mean (95% confidence intervals);
c Mean (SD)
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Figure 1 Comparison of MRI determined intra-abdominal fat
(IAF) and BMI in metabolically normal (MHO n = 20) and those
with any metabolic abnormality (MetAb n = 19). Geometric
mean presented for IAF; median IQR for BMI. The symbol * indicates
the groups are significantly different from each other (p<0.01)
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week, but these differences were not statistically signifi-
cant. Total energy expenditure for the 2 groups was
very similar for past year (slightly higher in MHOs) and
past week (slightly higher in MetAbs).
Although the groups did not differ significantly in
terms of their self-reported total energy expenditure
there was a significant difference between the groups in
the proportion of participants reporting meeting current
guidelines for the level of physical activity required to
have an impact on health. Seventy per cent of the MHO
group reported participating in at least 30 minutes of
moderate physical activity on at least 5 occasions per
week (the current UK Government guideline [30]),
compared to 25% of the MetAb group (p = 0.010).
Contribution of body fat distribution and physical activity
to metabolic status
In logistic regression analysis, a greater volume of IAF
was associated with higher risk of having a metabolic
abnormality (OR per litre increase in IAF = 1.48, 95%
CIs 1.07-2.05, p = 0.018). Subcutaneous abdominal fat,
thigh fat and total abdominal fat were not associated
with MHO status. Controlling for the effect of SCF, SCF
and BMI or SCF, BMI and waist circumference did not
affect the relationship between IAF volume and MHO
status (table 4). HOMA-estimated insulin resistance was
strongly significantly associated with an increased likeli-
hood of being MetAb (OR = 6.66, 95% CIs 1.57-28.16,
p = 0.01). When the effect of HOMA was controlled for
IAF was still significantly associated with metabolic sta-
tus (p = 0.046). IAF explained 14.5% of the variance in
MHO status. HOMA explained an additional 15%. An
interaction between IAF and HOMA was also found,
(OR = 1.31, 95% CIs 1.11-1.56) which explained slightly
more (32% for main effects plus interaction) of the var-
iance than IAF and HOMA together.
Meeting current UK Government guidelines for physi-
cal activity participation was negatively associated with
being MetAb (OR for meeting the guidelines = 0.14,
95% CIs 0.04-0.58, p-0.006) and explained 15.2% of the
variance. When IAF and physical activity were included
in the same model the effect of both was attenuated
only slightly. When HOMA was added to the model
HOMA and physical activity remained independent
predictors, together explaining 38.2% of the variance,
but IAF was no longer a statistically significant predictor
(p = 0.077), although it did contribute to the explana-
tory power of the model.
Discussion
We have demonstrated in this study of very obese women
that lower intra-abdominal fat volume, less insulin resis-
tance and higher level of physical activity are factors that
influence metabolic function beneficially. The results of
multivariable modelling suggest that each makes an inde-
pendent contribution to the risk of having a metabolic
abnormality, suggesting that the impact of physical activity
on metabolic health is independent of its effect on IAF
and that IAF itself makes an independent contribution
and does not only operate via insulin resistance. Our
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Figure 2 Comparison of abdominal subcutaneous fat (SCF),
thigh fat:IAF, waist:hip ratio (WHR) and HOMA-IR in
metabolically normal (MHO n = 20) and those with any
metabolic abnormality (MetAb n = 19. All values are geometric
means with 95% CI, except WHR (mean; 95% CI). The symbol *
indicates the groups are significantly different from each other
(p < 0.01)
Table 2 Correlations of fat volumes with fasting and
postload glucose, triglycerides, HDL, blood pressure and
HOMA-IR
IAF SCF
rr
Fasting glucose (mmol/l
-1) 0.21 0.15
2-hour glucose (mmol/l
-1) 0.31
† 0.08
Triglycerides (mmol/l
-1) 0.31 0.08
HDL cholesterol (mmol/l
-1) -0.34
† -0.02
SBP (mmHg) 0.35
† 0.24
DBP (mmHg) 0.31
† 0.41
†
HOMA-IR 0.25 0.23
† p < 0.05
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duals exist who are very obese (in this study median BMI
of 39.6) but remain metabolically normal.
However, together IAF, HOMA-IR and meeting cur-
rent guidelines for participation in physical activity
accounted for only a little over a third of the risk of
having a glucose, lipid or blood pressure abnormality in
this group of women. Much of the variance in metabolic
status in these women remains unexplained by the vari-
ables considered here.
In contrast to other studies [15,32,33] we did not find
an association between abdominal SCF and presence of
a metabolic abnormality. Although the MHO and
MetAb groups did not differ in volume of total abdom-
inal SCF, differences may exist in deep and superficial
subcutaneous fat depots, which were not examined in
this study. Alternatively, in this very obese population
SCF may play a less important role in the metabolic
complications of adiposity than in less obese groups.
Characteristics of IAF that support its importance in
terms of metabolic health, including the lower sensitivity
of IAF to the anti-lipolytic effect of insulin, greater sensi-
tivity to the lipolytic effect of catecholamines and role as
a source of cytokines have been well documented [5,34].
It has also been suggested that an excess of IAF may
act as a marker for an impairment in an individual’s
ability to store fat in the subcutaneous depot or to uti-
lise it efficiently within mitochondria [35]. This suggests
that the MHO women in this study are better able to
store fat appropriately than those with a metabolic
abnormality who store excess energy as IAF, and also
potentially in skeletal muscle and the liver.
Insulin resistance, as estimated by HOMA, was an
independent predictor of metabolic status, and explained
a comparable amount of the variance to IAF. It should
be noted, however, that it was to be expected that the
MHO women would have lower HOMA values as nor-
mal glycaemic control, a component of HOMA, was
part of the definition of MHO.
It was surprising that neither IAF nor SCF were signif-
icantly correlated with insulin resistance in this study.
This could be attributed to the use of HOMA-IR as a
proxy for insulin resistance in this study. Although
HOMA-IR and the euglycaemic hyperinsulinaemic glu-
cose clamp procedure have a good correlation in larger
studies (0.6-0.88) [36] HOMA-IR may have less utility
in a small study. Furthermore, HOMA-IR is closely cor-
related with fasting insulin and other investigators have
reported no association or a weak association between
fasting insulin and/or glucose and IAF [37,38] even
when a significant relationship between glucose disposal
and IAF exists [37].
The participants in this study, and especially those
with normal metabolic function, reported higher levels
of physical activity than have been reported in other stu-
dies, including, for example, the Health Survey for Eng-
land 2008, which reported only 19% of obese women
meet the current guideline [39]. The difficulties asso-
ciated with collecting data on physical activity level have
long been acknowledged [40]. However, there is no rea-
son to believe that the MHO and MetAb groups would
have reported their physical activity habits systematically
differently, and as the focus of the study was on differ-
ences between the two groups, this does not present a
major threat to the validity of these data. Nevertheless it
would be desirable in future work to have a more
sophisticated measure of physical activity using an accel-
erometer and/or heart rate monitoring to provide more
precise information on how energy expenditure and
physical activity duration and intensity differ between
those who maintain normal metabolic function and
those who develop an abnormality.
Table 3 Self-reported and pedometer recorded physical activity
MHO MetAb
n2 0 1 9 p
Mean (SD)/[CI] Mean (SD)/[CI]
Steps per day (pedometer)
a 6548.2 (2997.8) 5427.1 (2938.2) 0.252
DEE Past year leisure (Kcal)
b 236.4 [155.5-359.5] 167.5 [111.2-252.2] 0.332
DEE Past week leisure (Kcal)
b 239.2 [157.1-364.3] 151.9 [89.5-257.5] 0.244
DEE Past year occupational (Kcal)
b 484.9 [355.3-661.9] 508.2 [358.5-720.4] 0.851
DEE Past week occupational (Kcal)
b 513.3 [375.3-701.9] 498.3 [347.7-714.0] 0.912
Total DEE Past year (Kcal)
a 2687.5 (810.5) 2590.2 (684.5) 0.684
Total DEE Past week (Kcal)
a 2657.7 (818.4) 2711.7 (762.1) 0.830
% [95% CI] % [95% CI]
Moderate activity × 5 per week 70.0 [55.8-84.2] 25.0 [11.6-38.4] 0.010
DEE = Daily Energy Expenditure;
a Mean (SD), independent samples t-test for difference between MENO and MetAB;
b Geometric mean (95% confidence intervals [CIs])
Hayes et al. BMC Public Health 2010, 10:723
http://www.biomedcentral.com/1471-2458/10/723
Page 6 of 9Our results could have important public health and
clinical significance. Despite widespread awareness of
the negative consequences of excess adiposity and
efforts to redress or at least halt the rise in obesity, its
prevalence continues to increase. Not all obese indivi-
duals have the glucose, lipid and blood pressure
abnormalities usually associated with obesity. This sug-
gests that there is a need for a different approach to the
problem, which focuses on those most at risk of devel-
oping the ill health consequences of obesity and who
should be targeted for intervention. The findings of this
pilot study suggest that IAF accumulation, insulin
resistance and lack of physical activity each have an
i n d e p e n d e n tr o l et op l a yi ni d e n t i f y i n gt h o s em o s ta t
risk of the negative metabolic health consequences of
obesity. Future work should focus on strategies to iden-
tify individuals most likely to benefit from intervention,
for example, by encouraging the routine use of estab-
lished simple methods, including the measurement of
waist circumference and the use of dual energy X-ray
absorptiometry (DXA) where available, to identify those
likely to have high levels of IAF. In addition work is
needed to identify factors that drive deposition of fat in
the visceral depot. Many determinants of IAF accumula-
tion have been proposed, including genes [41], smoking
[42] and psychological stress [43], but the contribution
of these putative determinants has yet to be fully
elucidated.
It has been suggested that some of the previous
research linking obesity to poor health and mortality
has failed to take account adequately of physical activity
or physical fitness [44] and the relative contributions of
fitness and fatness to the development of CVD and its
associated risk factors is still debated [45]. Data from
this study support an increasing body of work that phy-
sical activity is important in terms of being metabolically
healthy, independently of adiposity [44]. This supports a
move away from a focus primarily on weight loss to
reduce CVD and diabetes risk and towards promoting
increased physical activity and cardiorespiratory fitness
[46] both for the beneficial effects on health it confers
independently of weight loss and its role as an impor-
tant weight management tool.
As discussed above, the factors that we identify
explain only a relatively small amount of the risk of hav-
ing a metabolic abnormality in these very obese women.
Future work should focus on identifying other contribu-
tory factors. One putative risk factor for poor metabolic
health is accumulation of fat in the liver. High liver fat
content leads to raised very low density lipoprotein
levels and is associated with dysglycaemia [47,48]. The
possibility that the women who had a metabolic
abnormality in this study had high liver fat content is
consistent with the suggestion that these women are
impaired in their ability to store fat appropriately in the
subcutaneous depot. In addition an association between
liver fat and habitual physical activity has been observed,
which is consistent with our findings [49]. Other factors
worthy of consideration include aspects of diet [50] and
duration of or age at onset of obesity [8].
Strengths of this study include the detailed metabolic
assessments and the accurate assessment of body fat dis-
tribution that were undertaken on each of the partici-
pants. The small number of participants in this study,
which arose from clinical observations and is intended
as a pilot study to inform future work, and the relatively
Table 4 Logistic regression analysis to identify
determinants of being MetAb
OR 95% CIs p
Univariate analysis
IAF 1.48 (1.07-2.05) 0.018
SCF 1.02 (0.94-1.11) 0.636
All abdominal fat 1.04 (0.97-1.12) 0.296
Thigh fat 0.99 (0.93-1.06) 0.836
HOMA-IR 6.66 (1.57-28.16) 0.010
Physically active
† 0.14 (0.04-0.58) 0.006
Multivariable analysis
IAF + SCF
IAF 1.68 (1.14-2.49) 0.009
SCF 0.92 (0.82-1.04) 0.194
IAF, SCF + BMI
IAF 1.68 (1.13-2.48) 0.010
SCF 0.91 (0.73-1.12) 0.376
BMI 1.02 (0.86-1.20) 0.853
IAF, SCF, BMI + waist
IAF 1.66 (1.08-2.55) 0.021
SCF 0.91 (0.73-1.13) 0.380
BMI 1.01 (0.83-1.23) 0.931
waist 1.01 (0.92-1.10) 0.911
IAF + HOMA-IR
IAF 1.39 (1.01-1.92) 0.046
HOMA-IR 5.36 (1.23-23.41) 0.025
IAF + Physically active
IAF 1.44 (1.02-2.03) 0.041
Physically active 0.19 (0.04-0.83) 0.028
IAF + HOMA-IR + Physically active
IAF 1.39 (0.98-2.01) 0.077
HOMA-IR 4.68 (1.13-19.4) 0.034
Physically active 0.16 (0.03-0.96) 0.045
† Defined as self-reporting being moderately active for 30 min at least 5 times
per week
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that were used for pragmatic reasons mean that the
strength of reported associations may have been under-
estimated, but nevertheless the substantial amount of
variance in metabolic status that remains unexplained
suggests that other factors remain to be identified.
Conclusion
In summary, our results confirm that individuals exist
who are obese but do not appear to suffer the negative
metabolic consequences of obesity. Lower levels of
intra-abdominal fat, less insulin resistance and higher
levels of physical activity are all associated with better
metabolic health even in very obese individuals. These
findings could be used to guide strategies to identify
those obese individuals most at risk of the negative
metabolic consequences of obesity. Intra-abdominal fat,
insulin resistance and physical activity together account
for only around a third of the risk of having a metabolic
abnormality in obese women. Future work should aim
to identify other contributory factors.
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